News
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
4h
Zacks Investment Research on MSNWill Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its ...
Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...
Medications known as GLP-1 inhibitors have made headlines in recent years due to their effectiveness in managing blood sugar ...
6h
ScienceAlert on MSNOzempic-Like Drugs Could Treat Chronic Migraines, Trial FindsMedications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...
When we feed the body correctly, we can influence the same systems that drugs like Mounjaro target - helping regulate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results